Chemokine receptors and virus entry in the central nervous system

Journal of NeuroVirology

Volumn 5, Issue 6, 1999, Pages 643-658

  Gabuzda, Dana ^a,b   Wang, Jianbin ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Brain; Chemokine receptor; Coreceptor; HIV 1; Microglia; SIV

Indexed keywords

BRAIN RECEPTOR; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; VIRUS RECEPTOR;

CENTRAL NERVOUS SYSTEM INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MICROGLIA; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION;

EID: 0033387213     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289909021293     Document Type: Review

References (171)

1. Albright AV, Shieh JTC, Itoh T, Lee B, Pleasure D, O'Connor MJ, Doms RW, Gonzalez-Scarano F (1999). Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol 73: 205 - 213.
2. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996). CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955 - 1958.
3. Baggiolini M, Dewald B, Moser B (1997). Human chemokines: An update. Annu Rev Immunol 15: 675 - 705.
4. Baldeweg T, Catalan J, Gazzard BG, Weiss RA, Boshoff C (1998). Kaposi's sarcoma and protection from HIV dementia. Science 280: 362.
5. Barroga CF, Ellis R, Nelson J, Heaton RK, Atkinson JH, McCutchan JA, Grant I, Spector SA (1997). HIV-1 neurocognitive disorders and chemokine receptors. AIDS 11: 1651 - 1664.
6. Berger EA (1997). HIV entry and tropism: the chemokine receptor connection. AIDS 11: (Suppl A) S3 - S16.
7. Berger EA, Murphy PM, Farber JM (1999). Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev Immunol 17: 657 - 700.
8. Berman JW, Guida MP, Warren J, Amat J, Brosnan CF (1996). Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J Immunol 156: 3017 - 3023.
9. Bernasconi S, Cinque P, Peri G, Sozzani S, Crociati A, Torri W, Vicenzi E, Vago L, Lazzarin A, Poli G, Mantovani A (1996). Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encophalitis. J Infec Dis 174: 1098 - 1101.
10. Berson JF, Doms RW (1998). Structure-function studies of the HIV-1 coreceptors. Sem in Immunol 10: 237 - 248.
11. Bieniasz PD, Fridell RA, Aramori I, Ferson SSG, Caron MG, Cullen BR (1997). HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor. EMBO J 16: 2599 - 2609.
12. Björndal Å, Deng H, Jansson M, Fiore JR, Colognesi C, Karlsson A, Albert J, Scarlatti G, Littman DR, Fenyö EM (1997). Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 71: 7478 - 7487.
13. Bleui CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA (1996). The lymphocyte chemo-attractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382: 829 - 833.
14. Bleui CC, Wu L, Hoxie JA, Springer TA, MacKay CR (1997). The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 94: 1925 - 1930.
15. Bolin LM, Murray R, Lukacs NW, Strieter RM, Kunkel SL, Schall TJ, Bacon KB (1998). Primary sensory neurons migrate in response to the chemokine RANTES. J Neuroimmunol 81: 49 - 57.
16. Brew BJ, Evans L, Byrne C, Pemberton L, Hurren L (1996). The relationship between AIDS dementia complex and the presence of macrophage tropic and non-syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid. J NeuroVirol 2: 152 - 157.
17. Cairns JS, D'Souza MP (1998). Chemokines and HIV-1 second receptors: The therapeutic connection. Nat Med 4: 563 - 568.
18. + T cells. Science 276: 273 - 276.
19. Chang J, Jozwiak R, Wang B, Ng T, Ge YC, Bolton W, Dwyer DE, Randle C, Osborn R, Cunningham AC, Saksena ND (1998). Unique HIV type 1 V3 region sequences derived from six different regions of brain: region-specific evolution within host-determined quasispecies. AIDS Res Hum Retroviruses 14: 25 - 30.
20. Chen Z, Zhou P, Ho DD, Landau N, Marx P (1997). Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for virus entry. J Virol 71: 2705 - 2714.
21. Cho MW, Lee ME, Carney MC, Berson JF, Doms RW, Martin MA (1998). Identification of determinants on a dual tropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. J Virol 72: 2509 - 2515.
22. Choe H, Farzan M, Konkel M, Martin K, Sun Y, Marcon L, Cayabyab M, Berman M, Dorf ME, Gerard N, Gerard C, Sodroski J (1998). The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J Virol 72: 6113 - 6118.
23. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, MacKay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J (1996). The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85: 1135 - 1148.
24. Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, Transidico P, Vagani A, Sozani S, Mantovani A, Lazzarin A, Poli G (1998). Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 12: 1327 - 1332.
25. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. (1995). Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811 - 1815.
26. Cocchi F, DeVico AL, Garzino-Demo A, Cara A, Gallo RC, Lusso P (1996). The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockage of infection. Nat Med 2: 1244 - 1247.
27. Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998). Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 95: 3117 - 3121.
28. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR (1997). Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 185: 621 - 628.
29. Davis CB, Dikie I, Unutmaz D, Hill CM, Arthos J, Siani MA, Thompson DA, Schlessinger J, Littman DR (1997). Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 186: 1793 - 1798.
30. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, O'Brien S (1996). Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273: 1856 - 1862.
31. Deng HK, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996). Identification of a major coreceptor for primary isolates of HIV-1. Nature 381: 661 - 666.
32. Deng HK, Unutmaz D, KewalRamani VN, Littman DR (1997). Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388: 296 - 300.
33. Di Marzio P, Jeffrey T, Landau NR (1998). Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages. AIDS Res Hum Retrovirus 14: 129 - 138.
34. Dimitrov DS, Norwood D, Stantchev TS, Feng Y, Xiao X, Broder CC (1999). A mechanism of resistance to HIV-1 entry: Inefficient interactions of CXCR4 with CD4 and gp120 in macrophages. Virology, 259: 1 - 6.
35. Dimitrov DS, Xiao X, Chabot DJ, Broder CC (1998). HIV Coreceptors. J Membrane Biol 166: 75 - 90.
36. Di Stefano M, Wilt S, Gray F, Dubois-Dalcq M, Chiodi F (1996). HIV Type 1 V3 sequences and the development of dementia during AIDS. AIDS Res and Hum Retroviruses 12: 471 - 476.
37. Doms RW, Peiper SC (1997). Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology 235: 179 - 190.
38. Donaldson YK, Bell JE, Holmes EC, Hughes ES, Brown HK, Simmonds P (1994). In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol 68: 5991 - 6005.
39. Donzella GA, Schols D, Lin SW, Este JA, Nagashima KA, Maddon PJ, Allaway GP, Sakmar TP, Henson G, De Clercq E, Moore JP (1998). AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 coreceptor. Nat Med 4: 72 - 77.
40. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW (1996). A dual-tropic primary HIV-1 isolate that uses fusin and the β chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85: 1149 - 1158.
41. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381: 667 - 673.
42. Dumonceaux J, Nisole S, Chanel C, Quivet L, Amara A, Baleux F, Briant P, Hazan U (1998). Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J Virol 72: 512 - 519.
43. Edinger AL, Clements JE, Doms RW (1999). Chemokine and orphan receptors in HIV-2 and SIV tropism and pathogenesis. Virology 260: 211 - 221.
44. Edinger AL, Hoffman TL, Sharron M, Lee B, O'Dowd B, Doms RW (1998a). )Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envlope proteins. Virology 249: 367 - 378.
45. Edinger AL, Hoffman TL, Sharron M, Lee B, Yi Y, Choe W, Kolson DL, Mitrovic B, Zhou Y, Faulds D, Collman RG, Hesselgesser J, Horuk R, Doms RW (1998b). An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus. J Virol 72: 7934 - 7940.
46. Edinger AL, Mankowski JC, Doranz BJ, Margulies BJ, Lee B, Rucker J, Sharron M, Hoffman TL, Benson JF, Zink MC, Hirsch VM, Clements JE, Doms RW (1997). CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci USA 94: 14742 - 14747.
47. Endres MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, McKnight A, Thomas JF, Stoebenau-Haggarty B, Choe S, Vance PJ, Wells TNC, Power CA, Sutterwala SS, Doms RW, Landau NR, Hoxie JA (1996). CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87: 745 - 756.
48. Eugen-Olsen J, Iversen AKN, Benfield TL, Koppelhus U, Garred P for the Copenhagen AIDS Cohort (1998). Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals. J Acq Im Def Syndromes 18: 110 - 116.
49. Farzan M, Choe H, Martin K, Marcon L, Hofmann W, Karlsson G, Sun Y, Barrett P, Marchand N, Sullivan N, Gerard N, Gerard C, Sodroski J (1997). Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med 186: 405 - 411.
50. Farzan M, Mirzabekov T, Kolchinsky P, Wyatt R, Cayabyab M, Gerard NP, Gerard C, Sodroski J, Choe H (1999). Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96: 667 - 676.
51. Feng Y, Broder CC, Kennedy PE, Berger EA (1996). HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272: 872 - 877.
52. Fitzgibbon JE, Gaur S, Gavai M, Gregory P, Frenkel LD, John Jr JF (1998). Effect of the HIV-1 syncytium-inducing phenotype on disease stage in vertically-infected children. J Med Virol 55: 56 - 63.
53. Gabuzda D, He J, Ohagen A, Vallat AV (1998). Chemokine receptors in HIV-1 infection of the central nervous system. Sem in Immunol 10: 203 - 213.
54. Gendelman HE, Lipton SA, Tardieu M, Bukrinsky MI, Nottet HS (1994). The neuropathogenesis of HIV-1 infection. J Leukoc Biol 56: 389 - 398.
55. Ghorpade A, Nukuna A, Che M, Haggerty S, Persidsky Y, Carter E, Carhart L, Shafer L, Gendelman HE (1998b). Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia. J Virol 72: 3340 - 3350.
56. Ghorpade A, Xia MQ, Hyman BT, Persidsky Y, Nukuna A, Bock P, Che M, Limoges J, Gendelman HE, MacKay CR (1998a). Role of the β-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J Virol 72: 3351 - 3361.
57. Glabinski AR, Ransohoff RM (1999). Chemokines and chemokine receptors in CNS pathology. J NeuroVirol 5: 3 - 12.
58. Godiska R, Chantry D, Dietsch GN, Gray PW (1995). Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 58: 167 - 176.
59. Gordon CJ, Muesing MA, Proudfoot AEI, Power CA, Moore JP, Trkola A (1999). Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J Virol 73: 684 - 694.
60. Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E. Stadel JM (1998). Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 273: 4282 - 4287.
61. Harouse JM, Bhat S, Spitalnik SL, Laughlin M, Stefano K, Silberberg DH, Gonzalez-Scarano F (1991). Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253: 320 - 323.
62. Harouse JM, Kunsch C, Hartle HT, Laughlin MA, Hoxie JA, Wigdahl B, Gonzalez-Scarano F (1989). CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol 63: 2527 - 2533.
63. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, Botti P, Bacon KB, Feng L (1998). Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 95: 10896 - 10901.
64. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Buscigilo J, Yang X, Hofmann W, Newman W, MacKay CR, Sodroski J, Gabuzda D. (1997). CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645 - 649.
65. Herbein G, Mahlknecht U, Batliwalla F, Gregersen P, Pappas T, Butler J, O'Brien WA and Verdin E (1998). Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 395: 189 - 194.
66. Hesselgesser J, Halks-Miller M, DelVecchio V, Peiper SC, Hoxie J, Kolson DL, Taub D, Horuk R (1997). CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr Biol 7: 112 - 121.
67. Hesselgesser J, Horuk R (1999). Chemokine and chemokine receptor expression in the central nervous system. J NeuroVirol 5: 13 - 26.
68. Hesselgesser J, Taub D, Baskar P, Greenberg M, Hoxie J, Kolson DL, Horuk R (1998). Neuronal apoptosis induced by HIV-gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4. Curr Biol 8: 595 - 598.
69. Hill CM, Kwon D, Jones M, Davis CB, Marmon S, Daugherty BL, DeMartino JA, Springer MS, Unutmaz D, Littman DR (1998). The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins. Virology 248: 357 - 371.
70. Horuk R, Hesselgesser J, Zhou Y, Faulds D, Halks-Millert M, Harvey S, Taub D, Samson M, Parmentier M, Rucker J, Doranz BJ, Doms RW (1998). The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-strains. J Biol Chem 273: 386 - 391.
71. Horuk R, Martin AW, Wang Z-X, Schweitzer L, Gerassimides A, Guo H, Lu Z-H, Hesselgesser J, Perez HD, Kim J, Parker J, Hadley TJ, Peiper SC (1997). Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158: 2882 - 2890.
72. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, Koup RA (1996). The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Medicine 2: 1240 - 1243.
73. gag and env genes. J Virol 71: 1272 - 1280.
74. Jansson M, Popovic M, Karlsson A, Cocchi F, Rossi P, Albert J, Wigzell H (1996). Sensitivity to inhibition by β-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc Natl Acad Sci USA 93: 15382 - 15387.
75. Jinno A, Shimizu N, Soda Y, Haraguchi Y, Kitamura T, Hoshino H (1998). Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection. Biochem Biophys Research Commun 243: 497 - 502.
76. mac chimeric virus whose env gene was derived from SIV-encephalitic brain is macrophage-tropic but not neurovirulent. J Virol 69: 1367 - 1369.
77. Kelly MD, Naif HM, Adams SL, Cunningham AL, Lloyd AR (1998). Dichotomous effects of β-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J Immunol 160: 3091 - 3095.
78. Keys B, Karis J, Fadeel B, Valentin A, Norkrans G, Hagberg L, Chiodi F (1993). V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology 196: 475 - 483.
79. Korber BTM, Kunstman KJ, Patterson BK, Furtado M, McEvilly MM, Levy R, Wolinsky SM (1994). Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 68: 7467 - 7481.
80. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, Deutsch L, Phair J, Neumann AU, Ho DD (1998). A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 4: 350 - 353.
81. Kozak SL, Platt EJ, Madani N, Ferro Jr FE, Peden K, Kabat D (1997). CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J Virol 71: 873 - 882.
82. Kunsch C, Hartle HT, Wigdahl B (1989). Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope. J Virol 63: 5054 - 5061.
83. Lapham CK, Zaitseva MB, Lee S, Romanstseva T, Golding H (1999). Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5. Nat Med 5: 303 - 308.
84. Lavi E, Kolson DL, Ulrich AM, Fu L, González-Scarano (1998). Chemokine receptors in the human brain and their relationship to HIV infection. J NeuroVirol 4: 301 - 311.
85. Lavi E, Strizki JM, Ulrich AM, Zhang W, Fu L, Wang Q, O'Connor M, Hoxie JA, González-Scarano F (1997). CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Path 151: 1035 - 1042.
86. Liao F, Alkhatib G, Peden KWC, Sharma G, Berger EA, Farber JM (1997). STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 185: 2015 - 2023.
87. Liestoel K, Goplen AK, Dunlop O, Bruun JN, Moehlen J (1998). Kaposi's sarcoma and protection from HIV dementia. Science 280: 361 - 362.
88. Lipton SA, Gendelman HE (1995). Dementia associated with the acquired immuno-deficiency syndrome. N Engl J Med 332: 934 - 940.
89. Littman DR (1998). Chemokine receptors: keys to AIDS pathogenesis? Cell 93: 677 - 680.
90. KU-2 that causes AIDS, neurological disease, and renal disease in rhesus macaques. Virology 260: 295 - 307.
91. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR (1996). Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367 - 377.
92. Luster AD (1998). Chemokines: chemotactic cytokines that mediate inflammation. N Eng J Med 338: 436 - 445.
93. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA (1998). Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1 deficient mice. Proc Natl Acad Sci USA 95: 9448 - 9453.
94. Mack M, Luckow B, Nelson PJ, Cihak J, Simmons G, Clapham PR, Signoret N, Marsh M, Stangassinger M, Borlat F, Wells TN, Schlondorff D, Proudfoot AE (1998). Amino-oxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J Exp Med 187: 1215 - 1224.
95. Madani N, Kozak SL, Kavanaugh MP, Kabat D (1998). gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5. Proc Natl Acad Sci USA 95: 8005 - 8010.
96. Mankowski JL, Spelman JP, Ressetar HG, Strandberg JD, Laterra J, Carter DL, Clements JE, Zink MC (1994). Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J Virol 68: 8202 - 8208.
97. mac239. J Virol 71: 2522 - 2527.
98. McManus CM, Brosnan CF, Berman JW (1998). Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia. J Immunol 160: 1449 - 1455.
99. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ (1998). Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 95: 14500 - 14505.
100. Michael NL, Louie LG, Rohrbaugh AL, Schultz KA, Dayhoff DE, Wang CE, Sheppard HW (1997). The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat Med 3: 1160 - 1162.
101. Michael NL, Moore JP (1999). HIV-1 entry inhibitors: Evading the issue. Nat Med 5: 740 - 742.
102. Mondor I, Ugolini S, Sattentau QJ (1998). HIV-1 attachment to HeLa CD4 cells is CD4-independent, gp120 dependent and requires cell surface heparans. J Virol 72: 3623 - 3634.
103. Moses AL, Bloom FE, Pauza CD, Nelson JA (1993). Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/ galactosylceramide-independent mechanism. Proc Natl Acad Sci USA 90: 10474 - 10478.
104. Mummidi S, Ahuja SS, Gonzalez E, Anderson SA, Santiago EN, Stephan KT, Craig FE, O'Ccnnell P, Tryon V, Clark RA, Dolan MJ, Ahuja SK (1998). Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 4: 786 - 793.
105. Nottet HSLM, Peridsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai Q-H, Sharer LR, McComb RD. Swindells S, Soderland C, Gendelman HE (1996). Mechanisms for the trans-endothelial migration of HIV-1-infected monocytes into brain. J Immunol 156: 1284 - 1295.
106. Oberlin E, Amara A, Bachelerie F, Bossia C, Virelizier J-L, Arenzana-Seisdedos F, Schwartz O, Heard J-M, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B (1996). The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382: 833 - 855.
107. Oh J-W, Schwiebert LM, Benveniste EN (1999). Cytokine regulation of CC and CXC chemokine expression by human astrocytes. J NeuroVirol 5: 82 - 94.
108. Öhagen A, Ghosh S, He J, Huang K, Chen Y, Yuan M, Osathanondh R, Gartner S, Shi B, Shaw G, Gabuzda D (1999). Apoptosis-induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: Evidence for a role of the envelope. J Virol 73: 897 - 906.
109. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, Vath J, Gosselin M, Ma J, Dussault B, Woolf E, Alperin G, Culpepper J, Gutierrez-Ramos JC, Gearing D (1997). Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387: 611 - 617.
110. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M (1997). A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 158: 3499 - 3510.
111. Peterson PK, Hu S, Salak-Johnson J, Molitor TW, Chao CC (1997). Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J Infec Dis 175: 478 - 481.
112. Petito CK, Cash KS (1992). Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 32: 658 - 666.
113. Platt EJ, Madiani N, Kozak SL, Kabat D (1997). Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor. J Virol 71: 883 - 890.
114. Pleskoff O, Tréboute C, Brelot A, Heveker N, Seman M, Alizon M (1997). Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 276: 1874 - 1878.
115. Power C, McArthur JC, Nath A, Wehrly K, Mayne M, Nishio J, Langelier T, Johnson RT, Chesebro B (1998). Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol 72: 9045 - 9053.
116. Power C, Kong P-A, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD (1993). Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 34: 339 - 350.
117. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, Chesebro B (1994). Demented and nondemented patients with AIDS differ in brain derived human immunodeficiency virus type 1 envelope sequences. J Virol 68: 4643 - 4649.
118. Price RW (1996). Neurological complications of HIV infection. Lancet 348: 445 - 452.
119. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS (1997). Unique monocyte subset in patients with AIDS dementia. Lancet 349: 692 - 695.
120. Ransohoff RM (1997). Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology. J Leuk Biol 62: 645 - 652.
121. Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohu VK (1993). Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7: 592 - 600.
122. Reddy RT, Achim CL, Sirko DA, Tehranchi S, Kraus FG, Wong-Staal F, Wiley CA, HIV Neurobehavioral Research Group (1996). Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis. AIDS Res Hum Retroviruses 12: 477 - 482.
123. Reeves JD, McKnight A, Potempa S, Simmons G, Gray PW, Power CA, Wells T, Weiss RA, Talbot SJ (1997). CD4-independent infection by HIV-2 (ROD/B): Use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology 231: 130 - 134.
124. Reeves JD, Schulz TF (1997). The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion. J Virol 71: 1453 - 1465.
125. Rizzuto CD, Wyatt R, Hernandez-Ramos N, Sun Y, Kwong PD, Hendrickson WA, Sodroski J (1998). A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280: 1949 - 1953.
126. Roderiquez G, Oravecz T, Yanagishita M, Bou-Habib DC, Mostowski H, Norcross MA (1995). Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J Virol 69: 2233 - 2239.
127. Rollins BJ (1997). Chemokines. Blood 90: 909 - 928.
128. Ross TM, Cullen BR (1998). The ability of human immunodeficiency virus type 1 to utilize CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic loop. Proc Natl Acad Sci USA 95: 7682 - 7686.
129. Rottman JB, Ganley KP, Williams K, Wu LJ, MacKay CR, Ringler DJ (1997). Cellular localization of the chemokine receptor CCR5 - Correlation to cellular target of HIV-1 infection. Am J Pathol 151: 1341 - 1351.
130. Rubbert A, Combadiere C, Ostrowski M, Arthos J, Dybul M, Machado E, Cohn MA, Hoxie JA, Murphy PM, Fauci AS, Weissman D (1998). Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. J Immunol 160: 3933 - 3941.
131. Rucker J, Doms RW (1998). Chemokine receptors as HIV coreceptors: Implications and interactions. AIDS Res Hum Retroviruses 14: (Suppl 3): S241 - S246.
132. Rucker J, Edinger AL, Sharron M, Samson M, Lee B, Berson JF, Yi Y, Margulies B, Collman RG, Doranz BJ, Parmentier M, Doms RW (1997). Utilization of chemokine receptors, orphan receptors, and herpes-virus-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 71: 8999 - 9007.
133. Sallusto F, Mackay CR, Lanzavecchia A (1997). Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005 - 2007.
134. Samson M, Edinger AL, Stordeur P, Rucker J, Verhasselt V, Sharron M, Govaerts C, Mollereau C, Vassart G, Doms RW, Parmentier M (1998). ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur J Immunol 28: 1689 - 1700.
135. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber C-M, Saragosti S, Lapouméroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M (1996). Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382: 722 - 725.
136. Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA and Achim CL (1998). Chemokines and receptors in HIV encephalitis. AIDS 12: 1021 - 1026.
137. Sasseville JG, Smith MM, MacKay CR, Pauley DR, Mensfield KG, Ringler DR, Lackner AA (1996). Chemokines expression in simian immunodeficiency virus-induced AIDS encephalitis. Am J Path 149: 1459 - 1467.
138. Schmidtmayerova H, Alfano M, Nuovo G, Bukrinsky M (1998). Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD-and CXCR4-mediated pathway: Replication is restricted at a postentry level. J Virol 72: 4633 - 4642.
139. Schmidtmayerova H, Nottet HSLM, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, Sherry B (1996). Human immunodeficiency virus type 1 infection alters chemokine β peptide expression in human monocytes: amplifications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 93: 700 - 704.
140. Schols D, Struyf S, Van Damme J, Este JA, Henson G, De Clercq E (1997). Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 186: 1383 - 1388.
141. Shieh JTC, Albright AV, Sharron M, Gartner S, Strizki J, Doms RW, Gonzalez-Scarano F (1998). Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. J Virol 72: 4243 - 4249.
142. Shi B, De Girolami U, He J, Wang S, Lorenzo A, Busciglio J, Gabuzda D (1996). Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Inves 98: 1979 - 1990.
143. Shimizu N, Soda Y, Kanbe K, Liu H-Y, Jinno A, Kitamura T, Hoshino H (1999). An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodeficiency virus Types 1 and 2 in brain-derived cells. J Virol 73: 5321 - 5239.
144. Simmonds P (1996). Neurotropism of HIV Type 1? AIDS Res Hum Retroviruses 12: 469 - 470.
145. Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM, Schwartz TW, Buser R, Wells TNC, Proudfoot AE (1997). Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276: 276 - 279.
146. Simmons G, Reeves JD, McKnight A, Dejucq N, Hibbitts S, Power CA, Aarons E, Schols D, De Clercq E, Proudfoot AEI, Clapham PR (1998). CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J Virol 72: 8453 - 8457.
147. Simmons G, Wilkinson D, Reeves JD, Dittmar M, Beddows S, Weber J, Carnegie G, Desselberger U, Gray PW, Weiss RA, Clapham PR (1996). Primary, syncytium-inducing human immunodeficiency virus type I isolates are dual-tropic and most can use either LESTR or CCR5 as coreceptors for virus entry. J Virol 70: 8355 - 8360.
148. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ (1997). Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277: 959 - 965.
149. Smyth RJ, Yi Y, Singh A, Collman RG (1998). Determinate of entry cofactor utilization and tropism in a dual tropic human immunodeficiency virus type 1 primary isolate. J Virol 72: 4478 - 4484.
150. Sørensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM (1999). Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103: 807 - 815.
151. Sozzani S, Ghezzi S, Iannolo G, Luini W, Borsatti A, Polentarutti N, Sica A, Locati M, Mackay C, Wells TNC, Biswas P, Vicenzi E, Poli G, Montani A (1998). Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 187: 439 - 444.
152. Strizki JM, Albright AV, Sheng H, O'Connor M, Perrin L, Gonzalez-Scarano F (1996). Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism. J Virol 70: 7654 - 7662.
153. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S-I, Kishimoto T, Nagasawa T (1998). The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393: 591 - 594.
154. Tanabe S, Heesen M, Yoshizawa I, Berman MA, Luo Y, Bleul CC, Springer TA, Okuda K, Gerard N, Dorf ME (1997). Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J Immunol 159: 905 - 911.
155. Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP, Cheng-Mayer C, Robinson J, Maddon PJ, Moore JP (1996). CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384: 184 - 187.
156. Vallat AV, De Girolami U, He J, Mhashilkar A, Marasco W, Shi B, Gray F, Bell J, Keohane C, Smith TW, Gabuzda D (1998). Localization of HIV-1 coreceptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 152: 167 - 178.
157. van Rij RP, Broersen S, Goudsmit J, Coutimho RA, Schuitemaker H (1998). The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection. AIDS 12: F85 - F90.
158. van'T Wout AB, Ran LJ, Kuiken CL, Kootstra NA, Pals ST, Schuitemaker H (1998). Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J Virol 72: 488 - 496.
159. Verani A, Pesenti E, Polo S, Tresoldi E, Scarlatti G, Lusso P, Siccardi AG, Vercelli D (1998). CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. J Immunol 161: 2084 - 2088.
160. Weissman D, Rabin RL, Arthos J, Rubbert A. Dybul M, Swofford R, Venkatesan S, Farber JM, Fauci AS (1997). Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389: 981 - 990.
161. Westmoreland SV, Rottman JB, Williams KC, Lackner AA, Sasseville VG (1998). Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. Am J Pathol 152: 659 - 665.
162. Willett BJ, Picard L, Hoxie MJ, Turner JD, Adema K, Clapham PR (1997). Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J Virol 71: 6407 - 6415.
163. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, O'Brien SJ (1998). Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort. Science 279: 389 - 393.
164. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJS, Richman, DD (1997). In vivo compartmentalization of human immunodeficiency Virus: evidence from the examination of pol sequences from autopsy tissues. J Virol 71: 2059 - 2071.
165. Wu L, Gerard N, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso A, Desjardins E, Newman W, Gerard C, Sodroski J (1996). CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384: 179 - 183.
166. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, MacKay CR (1997). CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1185: 1681 - 1691.
167. Yi Y, Rana S, Turner JD, Gaddis N, Collman RG (1998). CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J Virol 72: 772 - 777.
168. Zhang L, He T, Talal A, Wang G, Frankel SS, Ho DD. (1998). In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J Virol 72: 5035 - 5045.
169. Zheng J, Ghorpade A, Niemann D, Cotter RL, Thylin MR, Pestein L, Swartz JM, Shepard RB, Liu X, Nukuna A, Gendelman HE (1999a). Lymphotropic virons affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodefficiency virus type 1-associated dementia. J. Virol 73: 8256 - 8267.
170. Zheng J, Thylin MR, Ghorpade A, Xiong H, Persidsky Y, Cotter R, Niemann D, Che M, Zeug Y-C, Gelhard HA, Shepard RB, Swartz JM, Gendelman HE (1999b). Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J Neuroimmunol 98: 185 - 200.
171. Zou Y-R, Kottman AH, Koruda M, Taniuchi I, Littman DR (1998). Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595 - 599.